Tg Therapeutics TGTX
NASDAQ TGTX
$65.76 +1.50 (+2.33%)
At close: Nov 11, 2026 · 4:00 PM EST

Tg Therapeutics (TGTX) Acquisitions (2009 - 2011)

Updated

Tg Therapeutics' Acquisitions came in at $10,386 for FY2012.

Analysis

Tg Therapeutics (TGTX) Acquisitions (2009 - 2011) Analysis & Trends

  • Per Business Quant, earlier years put Acquisitions at $10,386 in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 887.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -17.15 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 10.59 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 630.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 19.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Tg Therapeutics 9.71 Bn 8.96 Bn 217.86 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2011 -10,386.00
Jun 30, 2011 -519,365.00
Mar 31, 2011 519,365.00
Dec 31, 2010 1.04 Mn
Jun 30, 2010 -1.04 Mn
Mar 31, 2010 519,365.00
Mar 31, 2009 -26,031.00
API Access

Tg Therapeutics Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=TGTX&period=max&api_key=YOUR_API_KEY